Advances in Electrospun Hybrid Nanofibers for Biomedical Applications

Nanomaterials (Basel). 2022 May 27;12(11):1829. doi: 10.3390/nano12111829.

Abstract

Electrospun hybrid nanofibers, based on functional agents immobilized in polymeric matrix, possess a unique combination of collective properties. These are beneficial for a wide range of applications, which include theranostics, filtration, catalysis, and tissue engineering, among others. The combination of functional agents in a nanofiber matrix offer accessibility to multifunctional nanocompartments with significantly improved mechanical, electrical, and chemical properties, along with better biocompatibility and biodegradability. This review summarizes recent work performed for the fabrication, characterization, and optimization of different hybrid nanofibers containing varieties of functional agents, such as laser ablated inorganic nanoparticles (NPs), which include, for instance, gold nanoparticles (Au NPs) and titanium nitride nanoparticles (TiNPs), perovskites, drugs, growth factors, and smart, inorganic polymers. Biocompatible and biodegradable polymers such as chitosan, cellulose, and polycaprolactone are very promising macromolecules as a nanofiber matrix for immobilizing such functional agents. The assimilation of such polymeric matrices with functional agents that possess wide varieties of characteristics require a modified approach towards electrospinning techniques such as coelectrospinning and template spinning. Additional focus within this review is devoted to the state of the art for the implementations of these approaches as viable options for the achievement of multifunctional hybrid nanofibers. Finally, recent advances and challenges, in particular, mass fabrication and prospects of hybrid nanofibers for tissue engineering and biomedical applications have been summarized.

Keywords: bone regeneration; drug delivery; electrospinning; functional agents; hybrid nanofibers; nanomedicine; nanoparticles; tissue engineering.

Publication types

  • Review

Grants and funding

The project received funding from EU Horizon 2020 MSCA-RISE-2018 Research and Innovation Staff Exchange Programme, project i-P OSTEO “Induced pluripotent stem cell for bone and cartilage defects” under the Marie Skłodowska-Curie grant agreement No 824007 and was partially supported by the Polish National Agency for Academic Exchange (NAWA) Grant PPI/APM/2018/1/00045/U/001.